Latest news with #Non-Hispanic
Yahoo
3 days ago
- Business
- Yahoo
Opinion - Trump's new DEI: Drama, exaggeration and incoherence
President Trump's war against diversity, equity and inclusion is reverberating throughout nearly every sector, igniting a civil rights pushback. But his executive orders ending DEI cannot halt the historic pace of national racial diversity. According to the Census Bureau, the 'white only' share of the population is now 58.4 percent. Non-Hispanic whites are projected to fall below 50 percent by 2045. So the 'D' in DEI represents America's destiny. Although contentious race-based policy debates will continue, diversity is the new America and must be embraced. The DEI acronym, along with tariffs, ranks among Trump's most frequent utterances. But due to overuse and clouded meaning, change is afoot to rename DEI, starting with the 'Office of Belonging' at the renowned Mayo Clinic. Therefore, I propose changing DEI to mean 'drama, exaggeration and incoherence,' reflecting Trump's unique communication and governing style. 'Drama' captures the daily, head-splitting, inescapable second Trump term. Every day is Trump Day, as Americans are surrounded by media and compelled to tune in. The president's insatiable desire to consolidate power, combined with his unconventional need to create drama, leads to constant breaking news that affects every citizen's life to some degree. Such intentional 'drama by design' could be perceived as a subtle form of domination. Through daily headlines — regardless of whether the news is good or bad, since bad news is spun, justified or rationalized as good — Trump keeps himself prominently on your screen. He 'wins the day' by overshadowing or blotting out others. His need to be on your screen evokes George Orwell's classic dystopian novel '1984,' written long before screen viewing became a daily ritual. In '1984,' a totalitarian state dominates and controls its people through pervasive surveillance via their 'telescreen.' Maintaining a constant screen presence is 'Big Brother,' the all-powerful leader who is always watching and enforcing ideological purity throughout the land. Remarkably, Trump maintains a communication advantage over the fictional Big Brother. He holds a 65 percent stake in Trump Media and Technology Group, which operates Truth Social, his primary communication platform, with a market capitalization of $5 billion. Thus, a drama-loving president who owns and controls his main media dissemination vehicle is rationalized as 'Trump being Trump.' Through Truth Social — an Orwellian sounding name — Trump crafts his version of 'truth.' He generates non-stop drama, attacks America's premier institutions, denigrates his enemies, spews factually incorrect statements, picks fights with celebrities and, most egregiously, conducts official presidential business with no filters or guardrails. How long will Americans tolerate the pace of Trump's move-fast-and-break-things presidency? What most affects presidential job approval ratings are the prices for food, gas, cars, homes and consumer goods. Rising costs and shortages driven by uncertainty due to Trump's tariffs, further complicated by this week's anti-tariff court ruling, and then blocked on appeal, suggest he could 'pay' in the midterms. More damaging is that Trump had promised to combat inflation, the key reason he won in 2024. The president, well aware of this problem, has instituted an ongoing operational plan to prevent Republicans from losing the House of Representatives. Trump also believes (with good reason) that a Democratic victory could trigger his third impeachment. Therefore, cue the 2026 election drama along with nonstop judicial drama. Exaggeration is Trump's default mode of communication. Since facts are often inconvenient, it's easier to use exaggerated words or phrases to enhance a narrative. Nearly every day, on any issue, Trump straddles the line between embellishment and outright lies, known in Trump-speak as 'alternative facts.' His flair for stretching the truth is baked into his always great, best-ever, big, beautiful persona. Although Trump continuously exaggerates his past, present and future achievements — most notably falsely claiming victory in the 2020 election — he occasionally faces the consequences of his exaggerations. After repeatedly saying, 'I will end the Ukraine-Russia war in 24 hours,' he now claims he was only speaking 'in jest.' Continuously fact-checking Trump's exaggerations is a thankless task, and why much of what he says goes unchecked and repeated as fact in Trump-friendly media, on X and Truth Social. Incoherence is Trump's enemy. His 79th birthday, coming in June, will bring more comparisons to former President Joe Biden's diminished mental state. And Trump is exhibiting increasingly bewildering behavior. At all hours, he is always on the attack, often posting bizarre Truth Social videos and tweets unbefitting of a president. Trump's Memorial Day 'scum' remarks and meandering West Point 'trophy wife' address, along with his usual 'weave' of rambling speech patterns bordering on gibberish, explains why the White House is purging its website of official transcripts. This action evokes another detail from '1984,' in which embarrassing documents are disappeared 'down the memory hole.' This new version of DEI represents our president governing through drama, exaggeration and incoherence, brazenly consolidating power with a 'dare you to stop me' attitude. That invites the question of what the presidency will look like after Trump. Do Americans prefer an all-powerful chief executive who enriches himself and tries to rule with fear and an iron fist? If so, Donald Trump Jr. could be our next president. Myra Adams is an opinion writer who served on the creative team of two Republican presidential campaigns in 2004 and 2008. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
The Hill
3 days ago
- Politics
- The Hill
Trump's new DEI: Drama, exaggeration and incoherence
President Trump's war against diversity, equity and inclusion is reverberating throughout nearly every sector, igniting a civil rights pushback. But his executive orders ending DEI cannot halt the historic pace of national racial diversity. According to the Census Bureau, the 'white only' share of the population is now 58.4 percent. Non-Hispanic whites are projected to fall below 50 percent by 2045. So the 'D' in DEI represents America's destiny. Although contentious race-based policy debates will continue, diversity is the new America and must be embraced. The DEI acronym, along with tariffs, ranks among Trump's most frequent utterances. But due to overuse and clouded meaning, change is afoot to rename DEI, starting with the 'Office of Belonging' at the renowned Mayo Clinic. Therefore, I propose changing DEI to mean 'drama, exaggeration and incoherence,' reflecting Trump's unique communication and governing style. 'Drama' captures the daily, head-splitting, inescapable second Trump term. Every day is Trump Day, as Americans are surrounded by media and compelled to tune in. The president's insatiable desire to consolidate power, combined with his unconventional need to create drama, leads to constant breaking news that affects every citizen's life to some degree. Such intentional 'drama by design' could be perceived as a subtle form of domination. Through daily headlines — regardless of whether the news is good or bad, since bad news is spun, justified or rationalized as good — Trump keeps himself prominently on your screen. He 'wins the day' by overshadowing or blotting out others. His need to be on your screen evokes George Orwell's classic dystopian novel '1984,' written long before screen viewing became a daily ritual. In '1984,' a totalitarian state dominates and controls its people through pervasive surveillance via their 'telescreen.' Maintaining a constant screen presence is 'Big Brother,' the all-powerful leader who is always watching and enforcing ideological purity throughout the land. Remarkably, Trump maintains a communication advantage over the fictional Big Brother. He holds a 65 percent stake in Trump Media and Technology Group, which operates Truth Social, his primary communication platform, with a market capitalization of $5 billion. Thus, a drama-loving president who owns and controls his main media dissemination vehicle is rationalized as 'Trump being Trump.' Through Truth Social — an Orwellian sounding name — Trump crafts his version of 'truth.' He generates non-stop drama, attacks America's premier institutions, denigrates his enemies, spews factually incorrect statements, picks fights with celebrities and, most egregiously, conducts official presidential business with no filters or guardrails. How long will Americans tolerate the pace of Trump's move-fast-and-break-things presidency? What most affects presidential job approval ratings are the prices for food, gas, cars, homes and consumer goods. Rising costs and shortages driven by uncertainty due to Trump's tariffs, further complicated by this week's anti-tariff court ruling, and then blocked on appeal, suggest he could 'pay' in the midterms. More damaging is that Trump had promised to combat inflation, the key reason he won in 2024. The president, well aware of this problem, has instituted an ongoing operational plan to prevent Republicans from losing the House of Representatives. Trump also believes (with good reason) that a Democratic victory could trigger his third impeachment. Therefore, cue the 2026 election drama along with nonstop judicial drama. Exaggeration is Trump's default mode of communication. Since facts are often inconvenient, it's easier to use exaggerated words or phrases to enhance a narrative. Nearly every day, on any issue, Trump straddles the line between embellishment and outright lies, known in Trump-speak as 'alternative facts.' His flair for stretching the truth is baked into his always great, best-ever, big, beautiful persona. Although Trump continuously exaggerates his past, present and future achievements — most notably falsely claiming victory in the 2020 election — he occasionally faces the consequences of his exaggerations. After repeatedly saying, 'I will end the Ukraine-Russia war in 24 hours,' he now claims he was only speaking 'in jest.' Continuously fact-checking Trump's exaggerations is a thankless task, and why much of what he says goes unchecked and repeated as fact in Trump-friendly media, on X and Truth Social. Incoherence is Trump's enemy. His 79th birthday, coming in June, will bring more comparisons to former President Joe Biden's diminished mental state. And Trump is exhibiting increasingly bewildering behavior. At all hours, he is always on the attack, often posting bizarre Truth Social videos and tweets unbefitting of a president. Trump's Memorial Day 'scum' remarks and meandering West Point 'trophy wife' address, along with his usual 'weave' of rambling speech patterns bordering on gibberish, explains why the White House is purging its website of official transcripts. This action evokes another detail from '1984,' in which embarrassing documents are disappeared 'down the memory hole.' This new version of DEI represents our president governing through drama, exaggeration and incoherence, brazenly consolidating power with a 'dare you to stop me' attitude. That invites the question of what the presidency will look like after Trump. Do Americans prefer an all-powerful chief executive who enriches himself and tries to rule with fear and an iron fist? If so, Donald Trump Jr. could be our next president. Myra Adams is an opinion writer who served on the creative team of two Republican presidential campaigns in 2004 and 2008.
Observer
02-05-2025
- Health
- Observer
Breast cancer is becoming less deadly for younger women: US study
Young US women with breast cancer are not dying from the disease as often as a decade ago, researchers reported at the American Association for Cancer Research 2025 meeting in Chicago. From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial and ethnic groups, with marked declines starting after 2016, according to an analysis of data from the national Surveillance, Epidemiology and End Results registry. Overall, the breast cancer death rate in this age group fell from 9.70 per 100,000 women in 2010 to 1.47/100,000 in 2020. The decline was sharper after 2016, likely due to advancements in treatment options, greater uptake of precision medicine, and expanded access to care and screening in women ages 40-49, study leader Adetunji Toriola of the Washington University School of Medicine in St. Louis said in a statement. While breast cancer mortality declined in every racial and ethnic group, non-Hispanic Black women had the highest rate in both 2010 (16.56/100,000) and 2020 (3.41/100,000). Non-Hispanic white women had the lowest rates in 2010 (9.18/100,000) and 2020 (1.16/100,000). 'We have made tremendous advances in reducing mortality from breast cancer in young women but there are still opportunities for improvements, especially in relation to eliminating disparities,' Toriola said. 'We must continue to perform impactful research to ensure a further reduction in breast cancer mortality, including research into understanding the tumour biology and molecular mechanisms driving carcinogenesis and treatment response in younger women.' GLP-1 DRUGS MAY CURB ATRIAL FIBRILLATION GLP-1 drugs that are used to treat diabetes and have become wildly popular for weight loss, may also be useful for controlling the common heart rhythm disorder atrial fibrillation, researchers reported at the Heart Rhythm 2025 meeting in San Diego. Researchers looked at more than 2,500 patients with type 2 diabetes, atrial fibrillation and obesity at 170 US Veterans Affairs medical centres. Those who were receiving a GLP-1 drug experienced a 13% reduction in major AF-related events during a median follow-up of three years, compared to patients receiving other medications for their diabetes. AF-related events included hospitalisations for the disorder, need for electroshock therapy to reset the heart rhythm, and ablation procedures to heat heart tissue in order to create scars that interrupt the electrical signals causing the arrhythmia. Researchers did not identify the drugs being taken but common examples of GLP-1 medicines for diabetes include Novo Nordisk's Ozempic, Rybelsus and Victoza, and Eli Lilly's Mounjaro and Trulicity. Because patients were taking low doses of GLP-1 drugs, rather than higher doses used for weight loss, the results suggest the arrhythmia benefits are independent of any weight-loss benefit, the researchers noted. The study was not designed to prove the GLP-1 drugs caused the reduction in AF events. But study leader Dr Varun Sundaram of the Louis Stokes Cleveland VA Medical Center and Case Western Reserve University said, 'Given the growing obesity epidemic and the rising prevalence of atrial fibrillation,' it lays the foundation for a new approach to treating AF if larger trials confirm the potential benefits. — Reuters
Time of India
02-05-2025
- Health
- Time of India
Breast cancer is becoming less deadly for younger women, US study finds
London: Young U.S. women with breast cancer are not dying from the disease as often as a decade ago, researchers reported at the American Association for Cancer Research 2025 meeting in Chicago. From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial and ethnic groups, with marked declines starting after 2016, according to an analysis of data from the national Surveillance, Epidemiology, and End Results registry. Overall, the breast cancer death rate in this age group fell from 9.70 per 100,000 women in 2010 to 1.47/100,000 in 2020. The decline was sharper after 2016, likely due to advancements in treatment options, greater uptake of precision medicine, and expanded access to care and screening in women ages 40-49, study leader Adetunji Toriola of the Washington University School of Medicine in St. Louis said in a statement. While breast cancer mortality declined in every racial and ethnic group, non-Hispanic Black women had the highest rate in both 2010 (16.56/100,000) and 2020 (3.41/100,000). Non-Hispanic white women had the lowest rates in 2010 (9.18/100,000) and 2020 (1.16/100,000). "We have made tremendous advances in reducing mortality from breast cancer in young women but there are still opportunities for improvements, especially in relation to eliminating disparities," Toriola said. "We must continue to perform impactful research to ensure further reduction in breast cancer mortality, including research into understanding the tumor biology and molecular mechanisms driving carcinogenesis and treatment response in younger women." GLP-1 DRUGS MAY CURB ATRIAL FIBRILLATION GLP-1 drugs that are used to treat diabetes and have become wildly popular for weight loss, may also be useful for controlling the common heart rhythm disorder atrial fibrillation, researchers reported at the Heart Rhythm 2025 meeting in San Diego. Researchers looked at more than 2,500 patients with type 2 diabetes, atrial fibrillation and obesity at 170 U.S. Veterans Affairs medical centers. Those who were receiving a GLP-1 drug experienced a 13% reduction in major AF-related events during a median follow-up of three years, compared to patients receiving other medications for their diabetes. AF-related events included hospitalizations for the disorder, need for electroshock therapy to reset the heart rhythm, and ablation procedures to heat heart tissue in order to create scars that interrupt the electrical signals causing the arrhythmia. Researchers did not identify the drugs being taken but common examples of GLP-1 medicines for diabetes include Novo Nordisk's Ozempic, Rybelsus and Victoza, and Eli Lilly's Mounjaro and Trulicity. Because patients were taking low doses of GLP-1 drugs, rather than higher doses used for weight loss, the results suggest the arrhythmia benefits are independent of any weight-loss benefit, the researchers noted. The study was not designed to prove the GLP-1 drugs caused the reduction in AF events. But study leader Dr. Varun Sundaram of the Louis Stokes Cleveland VA Medical Center and Case Western Reserve University said, "given the growing obesity epidemic and the rising prevalence of atrial fibrillation," it lays the foundation for a new approach to treating AF if larger trials confirm the potential benefits.
